Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias – Vitali et al. Neurology 76 May 17, 2011.

Slides:



Advertisements
Similar presentations
Prion Disease Transmissible spongiform encephalopathy (TSE)
Advertisements

Interpretation of magnetic resonance imaging in the chronic phase of traumatic brain injury Jussi Laalo 1, Timo Kurki 2, Olli Tenovuo* 3 1 Department of.
DEMENTIA Leena Patel GPSTR. Overview  Causes of dementia  Differential diagnosis  Dementia and QOF.
Estate Planning and the Neuropsychologist
Prion diseases or transmissible spongiform encephalopathies (TSEs) rare progressive neurodegenerative disorders that affect both humans and animals. They.
CLINICAL ASPECTS OF BIOCHEMISTRY NEURODEGENERATIVE DISEASES Prion diseases Alzheimer's disease.
Dementia with Lewy Bodies
Mild Cognitive Impairment
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Rapid dementia Richard Lukose PGY-3 Neurology. 54 y/o male accountant presents to PCP 2 months progressively “acting strangely” per wife – Cannot remember.
Subtype of VaD: SIVD Subcortical Ischemic Vascular Disease Helena Chui, M.D. University of Southern California Rancho Los Amigos National Rehabilitation.
HIV dementia and HIV-related brain impairment (HRBI) Jeanette Meadway FRCP Consultant Physician Mildmay Hospital UK Hackney Road, London E2 7NA.
A ACHOUR, S JERBI OMEZZINE, S YOUNES 1, S BOUABID, MH SFAR 1, HA HAMZA. Department of Medical Imaging, Tahar Sfar University Hospital Center, Mahdia, Tunisia.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
PRION DISEASE & PENTOSAN POLYSULPHATE IN THE UK Richard Knight NCJDSU University of Edinburgh Scotland.
Holly Allen CREUTZFELDT-JAKOB DISEASE.  Human equivalent of mad cow disease  Rare, degenerative, fatal disease  Approximately 1 case per million per.
An update on diagnostics and management
Amyotrophic Lateral Sclerosis
CJD and Kuru: Prion Viruses By: Danny Nemeth. Prion infectious agent composed of protein in a misfolded form infectious agent composed of protein in a.
Prions: Proteins Gone Bad
By : Amirah nu’aimi Sharifah Nurul Hanim TASK 2 – DISCUSS THE EXAMPLE OF PROTEIN FOLDING DISEASE BY STATING THE MECHANISM.
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
Fondazione IRCCS – Istituto Neurologico “Carlo Besta” Milano Gerstmann-Sträussler-Scheinker disease Fabrizio Tagliavini.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
* Creutzfeldt–Jakob disease Posterior Reversible Encephalopathy Syndrome Progressive Multifocal Leukoencephalopathy.
EP Visualization of Perivascular Spaces on 3T MR Images of Alzheimer Patients: University Hospital-based Dementia Cohort Study Toshinori Hirai.
Oregon Health & Science University and Northwest PADRECC
Jalal Jalal Shokouhi – MD
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Neuroimaging in Neuropsychiatry
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease: A Magnetic Resonance Imaging Study Bartzokis, et al. UCLA.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
COMPARATIVE LATERALIZING ABILITY of MULTIMODALITY MR IMAGING in TEMPORAL LOBE EPILEPSY ¹ Karabekir Ercan, M.D. ¹ ¹ H.Pinar Gunbey, M.D. ¹ ¹ Elcin Zan,
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
T2 FLAIR Increased Signal Intensity at the Posterior Limb of the Internal Capsule: Clinical Significance in ALS Patients G. Protogerou 1, S. Ralli 2, I.
Used to be called Dementia Neurocognitive Disorders.
Magnetic Resonance Imaging In Young Patients With Neuro - Psychiatric SLE : A Case Series Dr. Vivek Gupta Department of Radiodiagnosis Postgraduate Institute.
Núria Bargalló, Teresa Lema,Mar Carreño, Antonio Donaire, Javier Aparicio, Iratxe Maestro. Hospital Clínic i Provincial de Barcelona MRI Changes In Status.
Types of dementia Dr Johan Schoeman Consultant in Old Age Psychiatry SEPT in Luton and Bedfordshire 2 nd November 2010.
Electrophysiology & Leukodystrophies Shahriar Nafissi Department of Neurology Tehran University of Medical Sciences.
Sint Lucas-Andreas Hospital, Amsterdam
Excerpta #: EE-01 F Mossa-Basha 1, M Stone 1, N Shabeeb 2, D Pinkney 1, H Marin 1 1 Henry Ford Health System, Detroit, MI 2 Indiana University Health,
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Radiology Department J. Broncano, M. García de Eulate, J. Zubieta, P. Dominguez, J. Arias, M. Arraiza, G. Viteri, M. Simón Aparent diffusion coefficient.
Yael Hacohen, Kshitij Mankad, W
The Malfunctioning Mind: Degenerative Diseases of the Brain
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
The Malfunctioning Mind: Degenerative Diseases of the Brain
Radiological imaging of dementia.
Evidence of Morphologic Differences in Children with Down Syndrome who Develop Infantile Spasms. Nicholas Phillips1,3 , Asim Choudhri2, James Wheless1,
Unit 40 Dementia care.
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
DIFFUSION ABNORMALITY OF CORPUS CALLOSUM IN ALZHEIMER’S DISEASE
Autoimmune Encephalitis
Nat. Rev. Neurol. doi: /nrneurol
Coronal (above) and axial (below) views of brain imaging findings in selected young onset dementias (images reproduced by kind permission of Dr Hadi Manji.
Neurology Resident and Fellow Section
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Figure 2 Examples of lesions with and without central veins
A 74-year old woman with progressive amnesia
A–C, Case 1. A–C, Case 1. Typical white matter changes involving the corpus callosum and the pyramidal tracts (A and C, arrows), dilation of the lateral.
A 47-year-old man with HSE
Transmissible human proteopathies: an expanding field
NEUROIMAGING FINDINGS OF RARE NEURODEGENERATIVE DISEASES RELATED TO DEMENTIA SYMPTOMS INTRODUCTION: Neurodegenerative diseases are diversified group of.
Anti-voltage-gated calcium channel encephalitis.
Presentation transcript:

Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias – Vitali et al. Neurology 76 May 17, 2011

CJD degenerative neurological disorder that is incurable and invariably fatal due to a type of infectious protein called a prion Prions are misfolded proteins which replicate by promotes refolding of native proteins into the diseased state

CJD Types sCJD: Spontaneous or somatic mutation Familial/genetic CJD (fCJD): Mutations in gene (PRNP) that codes for the prion protein (5–10% of all CJD cases) Iatrogenic CJD: Infection from prion contaminated material vCJD: BSE in cattle is transmitted to humans through infected beef

Presents as a rapidly progressive dementia (RPD), but other (npRPD) disorders have similar presentation Many npRPD are treatable Important to diagnose CJD for infection control EEG & CSF biochem has limited utility in CJD dx

Aim Evaluate the sensitivity and specificity of FLAIR and DWI MRI for sCJD compared to a cohort of npRPD subjects Identify MRI features that differentiate CJD from other npRPD

Method - Subjects Retrospective case-control study Total of 90 included subjects (61 CJD : 29 npRPD) –in whom CJD was considered as a DDx –who had sufficient quality FLAIR and DWI imaging performed at UCSF Memory & Aging Centre between Dec 2000 and Feb 2007

61 CJD –48 sCJD (43/48 tested for PRNP mutation ie fCJD – all negative) 41 path proven 7 non-pathology proven cases, met WHO criteria –6 fCJD –7 GSS (Gerstmann–Sträussler– Scheinker syndrome) 29 npRPD –14/29 tested for PRNP: all negative –15/29 not pathologically proven, but included survival was outside the range of sCJD subjects (> 3 years) definitive (e.g., serological or genetic) evidence of another disorder and/or they improved with (or without) treatment.

npRPD diagnostic groupsSpecific diagnosis Total (N=29) Path- proven Serologi cally or genetic proven (N=5) Neurodegenerative dementiasTotal125 Corticobasal degeneration31 Frontotemporal dementia32 Alzheimer’s disease22 Dementia with Lewy Bodies2 Parkinson’s disease1 Unknown dementia1 Autoimmune or paraneoplastic encephalopathyTotal954 Antibody-mediated neuro-autoimmune disorder434 Hashimoto’s encephalopathy2 Sarcoidosis11 metastatic non-CNS Hodgkin’s lymphoma11 Multiple sclerosis1 Vascular dementiasStrokes2 TumorsCNS lymphoma22 InfectiousMeningoencephalitis22 Toxic- MetabolicTotal21 Alcoholic encephalopathy1 MELAS11

Exclusion criteria Some RPD subjects were initially excluded due to insufficient diagnostic confidence levels or diagnoses were not clear insufficient quality MRI*

Methods – MRI Acquisition 2 GE Signa 1.5T scanners FLAIR and DWI/DTI in axial planes; most had coronal planes Slice thickness varied from 3-5mm

Methods – Visual assessment Multiplanar independent review by two neuroradiologists blinded to clinical diagnosis –Reader 1: 4 years experience –Reader 2: 20 years experience Gray matter involvement on FLAIR and DWI reported according to 26 cortical and 5 cortical divisions per hemisphere Based on imaging findings, readers classified subjects as definitely, probably, probably not, or definitely not CJD according to prior MRI criteria Consensus review: if readers disagreed on diagnosis (?classification), MRI examined together to make a consensus diagnosis

Methods – Determining patterns of gray matter involement in sCJD Each of 31 hemispheric regions on DWI MRI was scored 0, 1, or 2, according to how many readers judged a region as hyperintense The percentage of subjects with sCJD with involvement of each brain region was determined by averaging the ratings of both readers Subjects with sCJD were categorized into 6 different patterns of gray matter involvement

Methods – Unblinded review and identifying differentiating features After consensus review, the readers re- examined the MRIs “unblinded” to identify crucial differentiating features. Modified sCJD MRI criteria based on the results of the analysis

Results - Sensitivity and specificity for diagnosing sCJD SensitivitySpecificity Reader 192%72% Reader 294%100% Consensus reached in all but 3 cases (1 sCJD, 2 npRPD) 96%93%

Pattern of FLAIR and DWI neocortical, limbic and subcortical hyperintensities in sCJD vs npRPD 60/61 sCJD had hyperintensities in neocortical, subcortical or limbic regions or in combination None had isolated limbic involvement Abnormalities more evident on DWI > FLAIR

Pattern of FLAIR and DWI neocortical, limbic and subcortical hyperintensities in sCJD vs npRPD 9/29 npRPD had abnormal gray matter hyperintensities All had limbic involvement (7 isolated; 2 cases with also subcortical involvement) Abnormalities more evident FLAIR > DWI

MRI features in genetic prion disease 5/6 fCJD had gray matter hyperintensities Overlapping pattern of MRI abnormality with sCJD 1/7 GSS read as positive 2/7 GSS had isolated limbic involvement 4/7 GSS no abnormality

MRI unblinding False positives due to misinterpreting artifactual hyperintense signals on DWI as restricted diffusion (?without looking at ADC) False negatives due to failure to notice diffuse hyperintense cortical signals in subjects without subcortical abnormalities

Cases without MRI diagnosis at consensus review 1 sCJD 1 sarcoid 1 dementia with Lewy Bodies

Improving MRI criteria for sCJD MRI criteria for sCJD modified given the findings above Unblinded consensus review –98% sensitivity –100% specificity

Discussion In sCJD hyperintensity on DWI > FLAIR In npRPD hyperintensity on FLAIR > DWI Subcortical DWI hyperintensity in sCJD always associated with ADC hypointensity ie. Diffusion restriction (which is thought to be due to vacuolation) *Diffusion restriction may decline in late stages of sCJD → therefore early MRI may yield better sensitivity than later MRI

Discussion Other npRPD conditions not included in the study cohort (eg. Extrapontine myelinolysis, Wilson’s disease, Wernicke encephalopathy and Bartonella infection) may have MRI features that mimic sCJD

Discussion Isolated limbic involvement only seen in npRPD (and GSS) If isolated limbic involvement is seen FLAIR > DWI → “probably not CJD” If isolated limbic involvement is seen DWI > FLAIR, particularly with diffusion restriction → consider encephalitis and seizures

fCJD MRI pattern closely resembles sCJD This MRI pattern not found in GSS

Reader variability

Conclusion Patterns of FLAIR and DWI abnormalities can differentiate sCJD from npRPD Only some fCJD/GSS cases have overlapping features with sCJD MRI with DWI and ADC would be included in sCJD diagnostic criteria

Limitations ADC maps only examined only in cases with DWI hyperintensity Retrospective review after the study showed ADC hypointensities without DWI hyperintensity in some cases This may be due to “T2 blackout” effect caused by age related iron deposition in the GP and precental gyrus which cases hypointense signal and masks the hyperintense signal from prion disease